Detailed description page of B3Pdb


This page provides detail information of Selected ID b3pdb_0221
Primary information
B3PDB IDb3pdb_0221
Peptide NameNA
PEPTIDE SEQUENCE (1-letter)RGD
PEPTIDE SEQUENCE (3-letter)ArgGlyAsp
N-terminal modificationNA
C-terminal modificationNA
Chemical modificationNA
Peptide Length3
ConformationCyclic
Peptide NatureCationic
Source/Origin of peptideChemically synthesized
SMILESNA
Cell LineBCEC cell line
In vitro CONCENTRATION0.3 microgram of peptide per ml
In vitro METHODCompetition assay
In vitro RESULTNearly 7% diffuse into acceptor chamber after 8 hours
ANIMAL MODELNA
In vivo CONCENTRATIONNA
In vivo MODE OF DELIVERYNA
In vivo METHODNA
In vivo RESULTNA
ACTIONNA
TRANSPORT TYPENA
SUBCELLULAR LOCALISATIONNA
COMBINATIONpeptide combined with paclitaxel and Doxorubicin
PHYSICAL CONDITIONBrain glioma therapy
RESPONSENA
RESULTNA
LABELNA
PMID27143884